Bhalla Narinder Pal (CIK 2109299) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-01). Recent activity: Buy LXEO (55,000 shares), Sell LXEO (22,306 shares), Buy LXEO (49,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Medical Officer | Buy | 55,000 | $0 |
| 2026-07-01 | Lexeo Therapeutics, Inc. (LXEO) | Chief Medical Officer | Sell | 22,306 | $98,593 |
| 2026-02-17 | Lexeo Therapeutics, Inc. (LXEO) | Chief Medical Officer | Buy | 49,500 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-07-01